Hyaluronic acid preparations in the system of rehabilitation treatment for cartilage damage after arthroscopic surgeries on the knee joint
Keywords:hyaluronic acid, cartilage damage, arthroscopy, rehabilitation treatment, osteoarthritis, knee joint
The article presents the study on the effectiveness of proFLEX INTRA, a hyaluronic acid preparation, during rehabilitation after arthroscopic interventions in patients with damage to the articular cartilage of the knee joint. The study involved men and women aged 18–70 with Kellgren-Lawrence grade 1–2 knee osteoarthritis and cartilage lesions degree 2–4 according to R. Outerbridge; they underwent arthroscopic surgeries for various reasons. Patients were randomly assigned to the main (30 people) and control (30 individuals) groups. Patients of the main group on the 14th day after arthroscopic surgery on the knee joint received intraarticular injections of proFLEX INTRA (Delta Medical Promotions AG, Switzerland), 20 mg/ml 3 ml. It was found that the studied drug has a significant therapeutic effect in case of damage to the articular cartilage, which is manifested in a decrease in the severity of pain according to visual analogue scale; restoration of the function of the damaged joint evaluated by the time taken to cover a distance of 30 m and the Lequesne index; in reducing the severity of inflammatory and dystrophic manifestations in a biochemical blood test.
Lequesne M., Brandt K., Bellamy N. et al. Guidelines for testing slow acting an disease modifying drugs in osteoarthritis. J. Rheumatol. 1994. 21 (Suppl. 41). 65-71.
Group for the Respect of Ethics and Excellence in Science (GREES: osteoarthritis section): recommendations for the registration of drugs in the treatment of osteoarthritis. Ann. Rheum. Dis. 1996. 55. 552-557.
Altman R.D., Brandt K., Hochberg M. et al. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of Osteoarthritis Research Society. Results of a workshop. Osteoarthritis Cartillage. 1996. 4. 217-243.
Bellamy N., Kirwan J., Altman R.D. et al. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis: consensus development in OMERACT III. J. Rheumatol. 1997. 24. 799-802.
Desmarais M.H.L. Value of intra-articular injections in osteoarthritis. Ann. Rheum. Dis. 1952. 11. 277-281.
Aviad A.D., Houpt J.B. The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it? J. Rheumatol. 1994. 21. 297-301.
Abantangelo G., O’Regan M. Hyaluronan: biological role and function in articular joints. Eur. J. Rheumatol. Inflam. 1995. 15. 9-16.
George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann. Rheum. Dis. 1998. 57. 637-640.
Brandt K.D., Smith G.N., Simon L.S. Intraartricular injections of hyaluronan as treatment for knee osteoarthritis: what is the evidence? Arthritis Rheum. 2000. 43. 1192-1203.
Emmanuel Maheu, MD, François Rannou, MD, PhDb, Jean-Yves Reginster, MD, PhDc: Efficacy and safety of hyalu-ronic acid in the management of osteoarthritis: Evidence from real-life setting trials and surveys, Seminars in Arthritis and Rheumatism. 2016. 45. S28-S33.
Adams M.E., Lussier A.J., Peyron J.G. A risk-benefit assessment of injections of hyaluronan and it’s derivates in the treatment of osteoarthritis of the knee. Drug Saf. 2000. 23. 115-130.
Balazs E.A., Denlinger J.L. Viscosupplementation: a new concept in the treatment of osteoarthritis. J. Rheumatol. 1993. 20 (Suppl. 39). 3-9.
Waddell D.D. Viscosupplementation with hyaluronans for osteoarthritis of the knee: clinical efficacy and economic implications. Drugs Aging. 2007. 24. 629-642.
Altman R.D., Hochberg M.C., Moskowitz R.W., Schnitzer T.J., members of the ACR subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000. 43. 1905-1915.
Fernandes L., Hagen K.B., Bijlsma J.W., Andreassen O., Christensen P., Conaghan P.G. et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann. Rheum. Dis. 2013. 72. 1125-1135.
Akmal M., Singh A., Anand A., Kesani A., Aslam N., Goodship A., Bentley G. The effects of hyaluronic acid on articular chondrocytes. J. Bone Joint. Surg. Br. 2005. 87. 1143-1149.
Conrozier T., Balblanc J.C., Richette P., Mulleman D., Maillet B., Henrotin Y., Rannou F., Piroth C., Hilliquin P., Mathieu P., Walliser-Lohse A., Rousselot I., Plattner V., Maillefert J.F., Vignon E., Chevalier X. Early effect of hyaluronic acid intra-articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open-label observational prospective study. J. Orthop. Res. 2012. 30. 679-685.
Moreland L.W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res. Ther. 2003. 5. 54-67.
Guidolin D.D., Pasquali-Ronchetti I., Lini E. et al. Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500–730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthritis Cartilage. 2001. 9. 371-381.
Listrat V., Ayral X., Patarnello F., Bonvarlet J.P., Simonnet J., Amor B., Dougados M. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage. 1997. 5. 153-160.
Ghosh P., Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin. Arthritis Rheum. 2002. 32 (1). 10-37.
Frizziero L., Govoni E., Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin. Exp. Rheumatol. 1998. 16. 441-449.
Pasquali-Ronchetti I., Guerra D., Taparelli F., Boraldi F., Bergamini G., Mori G., Zizzi F., Frizziero L. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone ace-tate (Depomedrol) in osteoarthritis. Rheumatology. 2001. 40. 158-169.
Jubb R., Piva S., Beinat L. et al. Structure modifying study of hyaluronan (500–750 kDa, Hyalgan) on osteoarthritis of the knee. Arthritis Rheum. 2001. 44 (Suppl.). S155.
Disla E., Infante R., Fahmy A. et al. Recurrent acute calcium pyrophosphate dihydrate artritis following hyaluronate injection. Arthritis Rheum. 1999. 42. 1302-1303.
Lussier A., Cividino A.A., McFarlane C.A. et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J. Rheumatol. 1996. 23. 1579-1585.
Pullman-Mooar S., Mooar P., Sieck M. et al. Are there distinctive inflammatory flares of synovitis after Hylan GF intraarticular injections? Arthritis Rheum. 1999. 42 (9 Suppl.). S295.
Martens P.B. Bilateral symmetric inflammatory reaction to hylan G-F 20 injection. Arthritis Rheum. 2001. 44. 978-979.
Peyron J.G. A new approach to the treatment of ostheoarthritis: viscosupplementation. Osteoarthritis Cartillage. 1993. 1. 85-87.
Dougados M., Nguyen M., Listrat V., Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis Cartilage. 1993. 1. 97-103.
Henderson E.B., Smith E.C., Pegley F., Blake Dr. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Ann. Rheum. Dis. 1994. 53. 529-53.
Altman R.D. et al. The mechanism of action for hyalu-ronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015. 16. 321.
Xu X. et al. Hyaluronic acid-based hydrogels: from a Natural Polysaccharide to Complex Networks. Soft Matter. 2012. 8 (12). 3280-3294.
Fakhari A. Biomedical application of hyaluronic acid nanoparticles. PhD thesis. 2012.
Burdick J.A., Prestwich G.D. Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 2011. 23 (12). H41-H56
Collins M.N., Birkinshaw C. Hyaluronic acid based sca olds for tissue engineering: A review. Carbohyd. Polym. 2013. 92 (2). 1262-1279.
Yoshioka K. et al. Pharmacological e ects of novel cross-linked hyaluronate, Gel-200, in experimental animal models of osteoarthritis and human cell lines. Osteoarthr. Cartil. 2014 22 (6). 879-887
Sun S.F. et al. Comparison of single intra-articular injection of novel hyaluronan (HYA-JOINT Plus) with synvisc-one for knee osteoarthritis: a Randomized, Controlled, Double-Blind Trial of Ecacy and Safety. J. Bone Joint. Surg. Am. 2017. 99 (6). 462-471
Hangody L. et al. Intraarticular injection of a cross-linked sodium hyaluronate combined with triamcinolone hexacetonide (cingal) to provide symptomatic relief of osteoarthritis of the knee: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Trial. Cartilage. 2017. 1947603517703732.
Copyright (c) 2020 TRAUMA
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
- The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.